Clinical Trial Update: Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ticagrelor or prasugrel with clopidogrel in elderly patients with acute coronary syndrome at high bleeding risk has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Acute Coronary Syndrome
• Non-st-elevation Myocardial Infarction
• Unstable Angina

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: St. Antonius Hospital | Conditions: Non-ST-elevation Acute Coronary Syndrome, Unstable Angina | Phase 4 | Status: COMPLETED